Rockwell Medical, Inc. (RMTI) Stock Overview
Explore Rockwell Medical, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Rockwell Medical, Inc. (RMTI)
Key Financials
Key Financials
Market Cap
34.1M
P/E Ratio
-6.13
EPS (TTM)
$-1.34
ROE
-0.14%
RMTI Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Rockwell Medical, Inc. (NASDAQ: RMTI) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Rockwell Medical, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of RMTI on the NASDAQ shows an RSI of 63.09, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $2.83 for the NASDAQ listing.
Key metrics behind Rockwell Medical, Inc.'s NASDAQ-traded stock include a P/E ratio of -6.13 and a market capitalization of 34.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of RMTI on the NASDAQ.